The modern use of hydroxyurea for children with sickle cell anemia

Over the past 40 years, the introduction and refinement of hydroxyurea therapy has led to remarkable progress for the care of individuals with sickle cell anemia (SCA). From initial small proof-of-principle studies to multi-center Phase 3 controlled clinical trials and then numerous open-label stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Charles T. Quinn, Russell E. Ware
Format: Article
Language:English
Published: Ferrata Storti Foundation 2025-01-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/11891
Tags: Add Tag
No Tags, Be the first to tag this record!